(Q43051084)

English

Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines

scientific article published in April 1989

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Suppression of the generation of lymphokine-activated killer (LAK) cells by serum-free supernatants of in vitro maintained tumour cell lines (English)

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

author name string

Guillou PJ

1

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Ramsden CW

2

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Somers SS

3

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Sedman PC

4

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

language of work or name

0 references

publication date

1 April 1989

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

59

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

4

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

515-521

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

Inhibition of cytokine production by a tumor cell product.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Regression of a disseminated syngeneic solid tumor by systemic transfer of lymphoid cells expanded in interleukin 2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Lymphoid infiltration and prognosis in colorectal carcinoma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Human malignant and mitogen-transformed cells contain retroviral P15E-related antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Inhibition of interleukin 2 production by factors released from tumor cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Murine malignant cells synthesize a 19,000-dalton protein that is physicochemically and antigenically related to the immunosuppressive retroviral protein, P15E

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Lymphokine activated killer (LAK) cells in patients with gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Human colon cancer cell lines secrete alpha TGF-like activity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Clinical effects and toxicity of interleukin-2 in patients with cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Dissection of the lymphokine-activated killer phenomenon. Relative contribution of peripheral blood natural killer cells and T lymphocytes to cytolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Decreased interleukin-2 production in patients with gastrointestinal cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Adjuvant immunotherapy of established murine renal cancer by interleukin 2-stimulated cytotoxic lymphocytes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Lymphokine-activated killer cells. Analysis of progenitors and effectors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

The effect of interferon-gamma treatment of rat tumour cells on their susceptibility to natural killer cell, macrophage and cytotoxic T-cell killing.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Characterization of cells from invaded lymph nodes in patients with solid tumors. Lymphokine requirement for tumor-specific lymphoproliferative response

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Inhibition of lymphokine-activated killer cell generation by cultured tumor cell lines in vitro

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Inhibition of human natural killer cell activity by a synthetic peptide homologous to a conserved region in the retroviral protein, p15E.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Successful immunotherapy of murine experimental hepatic metastases with lymphokine-activated killer cells and recombinant interleukin 2.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Antitumor efficacy of lymphokine-activated killer cells and recombinant interleukin-2 in vivo: survival benefit and mechanisms of tumor escape in mice undergoing immunotherapy.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Separation and functional studies of the human lymphokine-activated killer cell.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2247131

26 May 2018

Functional properties of tumor-infiltrating and blood lymphocytes in patients with solid tumors: effects of tumor cells and their supernatants on proliferative responses of lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Production of transforming growth factors by human colon cancer lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cytolytic antitumor effector cells in long-term cultures of human tumor-infiltrating lymphocytes in recombinant interleukin 2

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsiveness

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Presence of activated T-cells with a T8+ M1+ Leu 7+ surface phenotype in invaded lymph nodes from patients with solid tumors

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of an immunosuppressive factor derived from colon cancer cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Generation of lymphokine-activated killer cells does not require DNA synthesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

In vivo delayed rejection of tumors and inhibition of delayed-type hypersensitivity by HT-29 human colonic adenocarcinoma cell line

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Characterization of an inhibitor of cell division released in tumour cell cultures

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The mechanism of retrovirus suppression of human T cell proliferation in vitro

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identification and characterization of a tumor-derived immunosuppressive glycoprotein from murine melanoma K-1735

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal retroviruses

1 reference

https://pubmed.ncbi.nlm.nih.gov/2785396

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/BJC.1989.106

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PMC publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PMC publication ID

13 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43051084&oldid=2205768864"